Top compounds associated with response to LRRC26


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K44224150 CTRPv2 pan-cancer AAC 0.1 0.2
mRNA SMER-3 CTRPv2 pan-cancer AAC 0.056 0.2
mRNA thapsigargin gCSI pan-cancer AAC -0.084 0.2
mRNA JQ-1:MK-0752 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.05 0.2
mRNA Docetaxel gCSI pan-cancer AAC -0.078 0.2
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.047 0.2
mRNA Methotrexate CTRPv2 pan-cancer AAC -0.054 0.2
mRNA elocalcitol CTRPv2 pan-cancer AAC 0.05 0.2
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.05 0.2
mRNA itraconazole CTRPv2 pan-cancer AAC -0.055 0.2
Download CSV